Published online
doi:10.1084/jem.20070081
The Journal of Experimental Medicine, Vol. 204, No. 6, 1335-1347
The Rockefeller University Press, 0022-1007 $30.00
© Sather et al.
Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease
Blythe D. Sather1,2,
Piper Treuting3,
Nikole Perdue1,
Mike Miazgowicz2,
Jason D. Fontenot2,
Alexander Y. Rudensky2, and
Daniel J. Campbell1,2
1 Benaroya Research Institute, Seattle, WA 98101
2 Department of Immunology and 3 Department of Comparative Medicine, University of Washington School of Medicine, Seattle, WA 98195
CORRESPONDENCE Daniel J. Campbell: campbell{at}benaroyaresearch.org
CD4+Foxp3+ regulatory T cells (T reg) are essential for maintaining self-tolerance, but their functional mechanisms and sites of action in vivo are poorly defined. We examined the homing receptor expression and tissue distribution of T reg cells in the steady state and determined whether altering their distribution by removal of a single chemokine receptor impairs their ability to maintain tissue-specific peripheral tolerance. We found that T reg cells are distributed throughout all nonlymphoid tissues tested, and are particularly prevalent in the skin, where they express a unique CCR4+CD103hi phenotype. T reg cell expression of CCR4 and CD103 is induced by antigen-driven activation within subcutaneous lymph nodes, and accumulation of T reg cells in the skin and lung airways is impaired in the absence of CCR4 expression. Mice with a complete loss of CCR4 in the T reg cell compartment develop lymphocytic infiltration and severe inflammatory disease in the skin and lungs, accompanied by peripheral lymphadenopathy and increased differentiation of skin-tropic CD4+Foxp3+ T cells. Thus, selectively altering T reg cell distribution in vivo leads to the development of tissue-specific inflammatory disease.
Abbreviations used: APC, antigen-presenting cell; CT, cholera toxin; LC, Langerhans cell; PLN, peripheral LN; MLN, mesenteric LN.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Lahl, K., Mayer, C. T., Bopp, T., Huehn, J., Loddenkemper, C., Eberl, G., Wirnsberger, G., Dornmair, K., Geffers, R., Schmitt, E., Buer, J., Sparwasser, T.
(2009). Nonfunctional Regulatory T Cells and Defective Control of Th2 Cytokine Production in Natural Scurfy Mutant Mice. J. Immunol.
183: 5662-5672
[Abstract]
[Full Text]
-
Igyarto, B. Z., Jenison, M. C., Dudda, J. C., Roers, A., Muller, W., Koni, P. A., Campbell, D. J., Shlomchik, M. J., Kaplan, D. H.
(2009). Langerhans Cells Suppress Contact Hypersensitivity Responses Via Cognate CD4 Interaction and Langerhans Cell-Derived IL-10. J. Immunol.
183: 5085-5093
[Abstract]
[Full Text]
-
Menetrier-Caux, C., Gobert, M., Caux, C.
(2009). Differences in Tumor Regulatory T-Cell Localization and Activation Status Impact Patient Outcome. Cancer Res.
69: 7895-7898
[Abstract]
[Full Text]
-
Grindebacke, H., Stenstad, H., Quiding-Jarbrink, M., Waldenstrom, J., Adlerberth, I., Wold, A. E., Rudin, A.
(2009). Dynamic Development of Homing Receptor Expression and Memory Cell Differentiation of Infant CD4+CD25high Regulatory T Cells. J. Immunol.
183: 4360-4370
[Abstract]
[Full Text]
-
Nistala, K., Wedderburn, L. R.
(2009). Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford)
48: 602-606
[Abstract]
[Full Text]
-
Lin, Y.-C., Chang, L.-Y., Huang, C.-T., Peng, H.-M., Dutta, A., Chen, T.-C., Yeh, C.-T., Lin, C.-Y.
(2009). Effector/Memory but Not Naive Regulatory T Cells Are Responsible for the Loss of Concomitant Tumor Immunity. J. Immunol.
182: 6095-6104
[Abstract]
[Full Text]
-
Oh, U., Blevins, G., Griffith, C., Richert, N., Maric, D., Lee, C. R., McFarland, H., Jacobson, S.
(2009). Regulatory T Cells Are Reduced During Anti-CD25 Antibody Treatment of Multiple Sclerosis. Arch Neurol
66: 471-479
[Abstract]
[Full Text]
-
Chaput, N, Louafi, S, Bardier, A, Charlotte, F, Vaillant, J-C, Menegaux, F, Rosenzwajg, M, Lemoine, F, Klatzmann, D, Taieb, J
(2009). Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut
58: 520-529
[Abstract]
[Full Text]
-
Ji, J., Cloyd, M. W.
(2009). HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression. Int Immunol
21: 283-294
[Abstract]
[Full Text]
-
Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C., Doffin, A. C., Durand, I., Olive, D., Perez, S., Pasqual, N., Faure, C., Ray-Coquard, I., Puisieux, A., Caux, C., Blay, J.-Y., Menetrier-Caux, C.
(2009). Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome. Cancer Res.
69: 2000-2009
[Abstract]
[Full Text]
-
Lathrop, S. K., Santacruz, N. A., Pham, D., Luo, J., Hsieh, C.-S.
(2008). Antigen-specific peripheral shaping of the natural regulatory T cell population. JEM
205: 3105-3117
[Abstract]
[Full Text]
-
Abe, J., Ueha, S., Suzuki, J., Tokano, Y., Matsushima, K., Ishikawa, S.
(2008). Increased Foxp3+ CD4+ Regulatory T Cells with Intact Suppressive Activity but Altered Cellular Localization in Murine Lupus. Am. J. Pathol.
173: 1682-1692
[Abstract]
[Full Text]
-
Saito, K., Torii, M., Ma, N., Tsuchiya, T., Wang, L., Hori, T., Nagakubo, D., Nitta, N., Kanegasaki, S., Hieshima, K., Yoshie, O., Gabazza, E. C., Katayama, N., Shiku, H., Kuribayashi, K., Kato, T.
(2008). Differential Regulatory Function of Resting and Preactivated Allergen-Specific CD4+CD25+ Regulatory T Cells in Th2-Type Airway Inflammation. J. Immunol.
181: 6889-6897
[Abstract]
[Full Text]
-
Traeger, T., Kessler, W., Assfalg, V., Cziupka, K., Koerner, P., Dassow, C., Breitbach, K., Mikulcak, M., Steinmetz, I., Pfeffer, K., Heidecke, C.-D., Maier, S.
(2008). Detrimental Role of CC Chemokine Receptor 4 in Murine Polymicrobial Sepsis. Infect. Immun.
76: 5285-5293
[Abstract]
[Full Text]
-
Van, V. Q., Darwiche, J., Raymond, M., Lesage, S., Bouguermouh, S., Rubio, M., Sarfati, M.
(2008). Cutting Edge: CD47 Controls the In Vivo Proliferation and Homeostasis of Peripheral CD4+CD25+Foxp3+ Regulatory T Cells That Express CD103. J. Immunol.
181: 5204-5208
[Abstract]
[Full Text]
-
Bayry, J., Tchilian, E. Z., Davies, M. N., Forbes, E. K., Draper, S. J., Kaveri, S. V., Hill, A. V. S., Kazatchkine, M. D., Beverley, P. C. L., Flower, D. R., Tough, D. F.
(2008). In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination. Proc. Natl. Acad. Sci. USA
105: 10221-10226
[Abstract]
[Full Text]
-
Dudda, J. C., Perdue, N., Bachtanian, E., Campbell, D. J.
(2008). Foxp3+ regulatory T cells maintain immune homeostasis in the skin. JEM
205: 1559-1565
[Abstract]
[Full Text]
-
Winstead, C. J., Fraser, J. M., Khoruts, A.
(2008). Regulatory CD4+CD25+Foxp3+ T Cells Selectively Inhibit the Spontaneous Form of Lymphopenia-Induced Proliferation of Naive T Cells. J. Immunol.
180: 7305-7317
[Abstract]
[Full Text]
-
Qin, S., Sui, Y., Soloff, A. C., Fallert Junecko, B. A., Kirschner, D. E., Murphey-Corb, M. A., Watkins, S. C., Tarwater, P. M., Pease, J. E., Barratt-Boyes, S. M., Reinhart, T. A.
(2008). Chemokine and Cytokine Mediated Loss of Regulatory T Cells in Lymph Nodes during Pathogenic Simian Immunodeficiency Virus Infection. J. Immunol.
180: 5530-5536
[Abstract]
[Full Text]
-
Guo, Z., Jang, M. H., Otani, K., Bai, Z., Umemoto, E., Matsumoto, M., Nishiyama, M., Yamasaki, M., Ueha, S., Matsushima, K., Hirata, T., Miyasaka, M.
(2008). CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. Int Immunol
20: 307-315
[Abstract]
[Full Text]
-
Nagase, H., Jones, K. M., Anderson, C. F., Noben-Trauth, N.
(2007). Despite Increased CD4+Foxp3+ Cells within the Infection Site, BALB/c IL-4 Receptor-Deficient Mice Reveal CD4+Foxp3-Negative T Cells as a Source of IL-10 in Leishmania major Susceptibility. J. Immunol.
179: 2435-2444
[Abstract]
[Full Text]